Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2.

Genes, chromosomes & cancer - 1 Mar 1993

Mulligan L M, Gardner E, Smith B A, Mathew C G, Ponder B A

Abstract excerpt

Multiple endocrine neoplasia type 2 (MEN 2) is a familial cancer syndrome arising from mutation at a locus or loci in chromosome region 10p11.2-q11.2. The disease is characterized by medullary thyroid carcinoma (MTC) and pheochromocytoma (Pheo). To assess the genetic events in tumour initiation and progression in this disease, we have compiled an allelotype for MTC and Pheo tumours using polymorphic marker loci...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Chromosome Mapping
Share to DNA Probes

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Genes, Tumor Suppressor

Share to Genetic Markers

Share to Genotype

Share to Polymerase Chain Reaction

Source

Identifiers

PMID: 7682102
DOI: 10.1002/gcc.2870060307

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2.PMID 7682102Read ↗

Localization of putative tumor suppressor loci by genome-wide allelotyping in human pancreatic endocrine tumors.Semantic proximity Read ↗

Large-Scale Allelotype of Pancreaticobiliary Carcinoma Provides Quantitative Estimates of Genome-Wide Allelic LossSemantic proximity Read ↗

Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas.Semantic proximity Read ↗

Mapping a tumor suppressor gene to chromosome 2p13 in metanephric adenoma by microsatellite allelotyping.Semantic proximity Read ↗

Allelotyping of anaplastic thyroid carcinoma: frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q.Semantic proximity Read ↗

Deletion mapping on the distal third region of chromosome 1p in multiple endocrine neoplasia type IIA.Semantic proximity Read ↗

Multiple allelic deletions and intratumoral genetic heterogeneity in men1 pancreatic tumors.Semantic proximity Read ↗

Localization of the multiple endocrine neoplasia type I (MEN1) gene based on tumor loss of heterozygosity analysis.Semantic proximity Read ↗

Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16.Semantic proximity Read ↗

Novel pheochromocytoma susceptibility loci identified by integrative genomics.Semantic proximity Read ↗

Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological featuresSemantic proximity Read ↗

Allelotype of pancreatic acinar cell carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.